Halaven Post-Marketing Surveillance (PMS)

CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

NCT06183736 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line Therapy

NCT03017885 ·Status: COMPLETED

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

NCT00465725 ·Status: COMPLETED ·Phase: PHASE1

Nivestim™ in Treatment of Malignant Diseases

NCT01627990 ·Status: COMPLETED

Oral Docetaxel in Patients With Normal or Impaired Liver Function

NCT05084456 ·Status: WITHDRAWN ·Phase: PHASE1

Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer

NCT04225026 ·Status: TERMINATED ·Phase: PHASE2

Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs

NCT06317714 ·Status: RECRUITING

The Effect of LentinexHP® on Quality of Life in Stage IV Colorectal Cancer

NCT05954390 ·Status: UNKNOWN ·Phase: NA

A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors

NCT02792465 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of AL8326 in Healthy Subjects

NCT07132957 ·Status: COMPLETED ·Phase: PHASE1

Careseng 1370 for Chemotherapy-Induced Myelosuppression

NCT03692780 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

The Absorption, Metabolism and Excretion of [14C]D-0316 in Human

NCT04464551 ·Status: UNKNOWN ·Phase: PHASE1

Malnutrition and Sarcopenia Screening in Chemotherapy Patients

NCT07163286 ·Status: ACTIVE_NOT_RECRUITING

Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer

NCT00033345 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas

NCT01716689 ·Status: COMPLETED ·Phase: PHASE2

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

NCT00991094 ·Status: RECRUITING

Study of 124I-NM404 in Advanced Solid Malignancies

NCT01662284 ·Status: TERMINATED

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

NCT02833246 ·Status: COMPLETED ·Phase: NA

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

NCT00636545 ·Status: COMPLETED ·Phase: PHASE1

A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male Volunteers

NCT01756768 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

NCT01350115 ·Status: COMPLETED ·Phase: PHASE2

Optimizing the Management of Patients With Oral Therapy

NCT03623490 ·Status: TERMINATED ·Phase: NA

Lean Body Mass as a Determinant of Docetaxel Pharmacokinetics and Toxicity

NCT01621425 ·Status: COMPLETED

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

NCT02751385 ·Status: TERMINATED ·Phase: PHASE1

CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer

NCT05251714 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2